Correlation Between Zoetis and Marker Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zoetis and Marker Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zoetis and Marker Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zoetis Inc and Marker Therapeutics, you can compare the effects of market volatilities on Zoetis and Marker Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zoetis with a short position of Marker Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zoetis and Marker Therapeutics.
Diversification Opportunities for Zoetis and Marker Therapeutics
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Zoetis and Marker is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Zoetis Inc and Marker Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marker Therapeutics and Zoetis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zoetis Inc are associated (or correlated) with Marker Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marker Therapeutics has no effect on the direction of Zoetis i.e., Zoetis and Marker Therapeutics go up and down completely randomly.
Pair Corralation between Zoetis and Marker Therapeutics
Considering the 90-day investment horizon Zoetis Inc is expected to generate 0.21 times more return on investment than Marker Therapeutics. However, Zoetis Inc is 4.67 times less risky than Marker Therapeutics. It trades about -0.05 of its potential returns per unit of risk. Marker Therapeutics is currently generating about -0.16 per unit of risk. If you would invest 17,472 in Zoetis Inc on November 29, 2024 and sell it today you would lose (973.00) from holding Zoetis Inc or give up 5.57% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Zoetis Inc vs. Marker Therapeutics
Performance |
Timeline |
Zoetis Inc |
Marker Therapeutics |
Zoetis and Marker Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zoetis and Marker Therapeutics
The main advantage of trading using opposite Zoetis and Marker Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zoetis position performs unexpectedly, Marker Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marker Therapeutics will offset losses from the drop in Marker Therapeutics' long position.Zoetis vs. Emergent Biosolutions | Zoetis vs. Bausch Health Companies | Zoetis vs. Neurocrine Biosciences | Zoetis vs. Teva Pharma Industries |
Marker Therapeutics vs. Exicure | Marker Therapeutics vs. Protagenic Therapeutics | Marker Therapeutics vs. Pmv Pharmaceuticals | Marker Therapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
CEOs Directory Screen CEOs from public companies around the world | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |